Anonymous ID: 24518e March 2, 2022, 1:10 p.m. No.15765427   🗄️.is 🔗kun

>>15765352

 

Pfizer is responsible for the management post-authorization safety data on behalf of the

MAH BioNTech according to the Pharmacovigilance Agreement in place.

 

https://investors.biontech.de/static-files/e862a8ea-5d90-4672-acfb-34de57b58806

 

We may not be able to demonstrate sufficient efficacy or safety of our COVID-19 vaccine to obtain permanent regulatory approval in the United States, the United Kingdom, the European Union, or other countries

where it has been authorized for emergency use or granted conditional marketing approval

 

If we discover safety issues with our products, including our COVID-19 vaccine, that were not known at the time of approval or if we fail to comply with continuing regulatory requirements, commercialization efforts

for our products could be negatively affected, approved products could lose their approval or sales could be suspended, and our business and reputation could be materially harmed.